Researchers have discovered a class of lipids that prevent or reverse some of the harmful metabolic changes of diabetes and similar disorders in mice. These molecules might be therapeutic themselves, or they could lead researchers to new drugs. Barbara Kahn, George Richards Minot Professor of Medicine at Beth Israel Deaconess Medical Center, led the research.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?